ストックスクリーナーアプリを入手
0.0623
23.37%
0.0118
プレマーケット:
.06
-0.0023
-3.69%
前日終値:
$0.0505
開ける：
$0.0532
24時間の取引高:
43.04M
Relative Volume:
0.62
時価総額：
$9.36M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.96%
1か月 パフォーマンス:
-71.44%
6か月 パフォーマンス:
-82.32%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.0527
$0.065
1週間の範囲:
$0.048
$0.087
52週間の値動き範囲:
$0.0467
$10.95
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
名前
Cero Therapeutics Holdings Inc
セクター
電話
650-407-2376
住所
201 HASKINS WAY, SOUTH SAN FRANCISCO
CERO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
0.0623 | 9.36M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.18 | 105.12B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
714.47 | 78.51B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
629.99 | 37.67B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.25 | 31.37B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
114.13 | 27.36B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cero Therapeutics Holdings Inc (CERO) 最新ニュース
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Cero Therapeutics holdings sees $400,456 in stock sales by YK Bioventures - Investing.com Australia
Cero Therapeutics sees $383,369 in stock sales by YK Bioventures - Investing.com
CERo Therapeutics appoints Chris Ehrlich CEO - MSN
CERo Therapeutics Holdings, Inc. Appoints Chris Ehrlich CEO - Marketscreener.com
CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO - GlobeNewswire
CERo Therapeutics Names Chris Ehrlich Permanent CEO, Advances Novel Cancer Treatment Pipeline - StockTitan
Cero therapeutics investor Sloan Stuart sells $55,538 in stock By Investing.com - Investing.com India
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.69% - MSN
United States shares lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN
CERo Therapeutics Holdings Inc. (CERO) reports earnings - Quartzy
Selling Your CERo Therapeutics Holdings Inc (CERO) Stock? Here’s What You Need To Know - Stocks Register
Cero Therapeutics holdings sees $325,000 stock sale by YK Bioventures - Investing.com India
FDA clears CERo's new AML drug for phase 1 trials - Investing.com
FDA clears CERo's new AML drug for phase 1 trials By Investing.com - Investing.com UK
CERo Therapeutics, Inc. Receives FDA Clearance of - GlobeNewswire
CERo Therapeutics Secures FDA Clearance for Novel AML Treatment Clinical Trial | CERO Stock News - StockTitan
Pre-market Movers: ELAB, PHGE, CLDI, BJDX... - RTTNews
Nuclear stock Oklo jumps on data center partnership - Investing.com
U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn
CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data - TipRanks
United Therapeutics (UTHR) Stock Dips Amid Broader Biotech Indus - GuruFocus.com
CERo Therapeutics Holdings, Inc. (CERO): 173% Stock Surge Driven by Promising Preclinical Data for Lead Compound CER-1236 - BP Journal
Crude Oil Down 3%; Aramark Posts Upbeat Earnings - Benzinga
Nasdaq Moves Lower; Canaan Shares Surge - Benzinga
U.S. Stock market: Binah Capital Group(+105.01%) and CERo Therapeutics(+152.00%) see strong gains, RAPT Therapeutics(−44.12%) declines during mid day trading - Business Upturn
U.S. Stock market: RAPT Therapeutics drops 41% while CERo Therapeutics surges 136% in early trading - Business Upturn
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results - Benzinga
CERo Therapeutics, Inc. Presents Preclinical Data - GlobeNewswire
CERo's Cancer Drug Shows Breakthrough: Kills Ovarian Cancer Without Toxicity in Key Study | CERO Stock News - StockTitan
Decisive Dividend Corp (DE-X) QuotePress Release - The Globe and Mail
Cero Therapeutics faces NASDAQ delisting - Investing.com India
Cero Therapeutics faces NASDAQ delisting By Investing.com - Investing.com UK
Cero Therapeutics Faces NASDAQ Delisting Over Low Stock Price - Investing.com India
CERo Therapeutics updates on clinical hold and management changes - Investing.com India
CERo Therapeutics updates on clinical hold and management changes By Investing.com - Investing.com South Africa
CERo Therapeutics Holdings, Inc. Announces Submission of IND Clinical Hold Complete Response Letter - Marketscreener.com
CERo Therapeutics, Inc. Provides Corporate Update - The Bakersfield Californian
CERO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Are Investors Inclined To Sell Their CERo Therapeutics Holdings Inc. (NASDAQ: CERO) Holdings? - Stocks Register
A closer look at CERO’s price-to-free cash flow ratio - US Post News
CERo Therapeutics Holdings Inc.’s Market Journey: Closing Strong at 0.10, Up 0.63 - The Dwinnex
Take off with CERo Therapeutics Holdings Inc. (CERO): Get ready for trading - SETE News
Cero Therapeutics announces financial update and board changes - Investing.com India
Cero Therapeutics announces financial update and board changes By Investing.com - Investing.com South Africa
Cero Therapeutics Holdings Inc (CERO) 財務データ
Cero Therapeutics Holdings Inc (CERO) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Cero Therapeutics Holdings Inc (CERO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| YK Bioventures Opportunities G | 10% Owner |
Dec 12 '24 |
Sale |
0.07 |
1,614,541 |
113,018 |
16,004,077 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 11 '24 |
Sale |
0.08 |
1,343,801 |
107,504 |
17,618,618 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 06 '24 |
Sale |
0.12 |
1,236,874 |
148,425 |
21,383,909 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 10 '24 |
Sale |
0.09 |
1,570,947 |
141,385 |
18,962,419 |
| YK Bioventures Opportunities G | 10% Owner |
Dec 09 '24 |
Sale |
0.11 |
850,543 |
93,560 |
20,533,366 |
| SLOAN STUART M | 10% Owner |
Sep 25 '24 |
Sale |
0.10 |
532,486 |
55,538 |
21,067,956 |
| YK Bioventures Opportunities G | 10% Owner |
Oct 10 '24 |
Sale |
0.10 |
3,250,000 |
325,000 |
22,620,783 |
0.10%
0.76%
大文字化:
|
ボリューム (24 時間):